Lupin Launches Authorized Generic Version of Alinia

Tuesday April 13, 2021 at 2:06 pm

Mumbai, Baltimore, March 10, 2021: Global pharma major, Lupin Limited (Lupin), today announced the launch of the authorized generic version of Alinia® (nitazoxanide) Tablets, 500 mg of Romark Laboratories, L.C.

Nitazoxanide Tablets, 500 mg, are indicated in the treatment of diarrhea caused by Giardia lamblia or Cryptosporidium parvum in patients 12 years of age and older.

Nitazoxanide Tablets, 500 mg (RLD: Alinia®) had estimated annual sales of USD  56 million in the U.S. (IQVIA MAT January 2021).

Releted Blog